Human taste assessment should begin immediately after successful Phase I clinical studies, when clinical viability is established and formulation decisions become critical.
Early quantitative taste data:
Early palatability decisions shorten timelines and reduce overall program risk.
Senopsys uses GCP-compliant trained human sensory analysis panels to quantify aversive taste, aroma, mouthfeel, and texture attributes of APIs and drug product formulations.
Because human sensory perception remains the clinically relevant model for oral acceptability, this approach provides development data that instrumental methods alone cannot fully replicate.
Study outputs are used to guide formulation design, prototype comparison, and development strategy.
Yes. Senopsys studies are designed using controlled sensory methods and documented under quality systems appropriate for inclusion in regulatory submissions, including:
Reports support formulation rationale, palatability strategy, and excipient justification.
Human sensory systems remain the only clinically relevant model for human oral perception.
Trained pharmaceutical sensory panels can:
For many APIs, these combined effects define the true taste masking challenge.
This provides formulation teams with development data directly relevant to patient acceptability.
Senopsys supports taste assessment and taste masking across a wide range of dosage forms, including:
We also routinely work with potent, poorly soluble, and otherwise challenging APIs.
Many APIs have multiple aversive sensory attributes simultaneously, including bitterness, burning, numbing, unpleasant odor, and a long aftertaste. Identifying which attributes dominate is often the key to successful formulation strategy.
Senopsys may not be the best fit when:
When appropriate, we recommend alternative resources.
Explore selected publications, presentations, and case studies related to pharmaceutical palatability and taste masking.
Many formulation teams also benefit from a Lunch & Learn seminar—a scientific overview of taste perception, sensory data interpretation, taste masking strategy, and formulation decision-making in pharmaceutical development.
Contact Senopsys to schedule a scientific discussion.
Senopsys is the taste-masking development partner of choice for 15 of the top 25 global pharma companies as well as dozens of emerging and mid-size pharma and biotech companies.
Ask us questions, inquire about our services or schedule a “lunch and learn” seminar about the art and science of taste masking.